Profound neonatal lactic acidosis and renal tubulopathy in a patient with glycogen storage disease type IXɑ2 secondary to a de novo pathogenic variant in PHKA2
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 27, 100765
Abstract
No abstract availableKeywords
Funding Information
- PTC Therapeutics
- Astellas Pharma US
This publication has 19 references indexed in Scilit:
- Clinical application of whole-exome sequencing across clinical indicationsGenetics in Medicine, 2016
- PHKA2 mutation spectrum in Korean patients with glycogen storage disease type IX: prevalence of deletion mutationsBMC Medical Genetics, 2016
- Aggressive therapy improves cirrhosis in glycogen storage disease type IXMolecular Genetics and Metabolism, 2013
- Lactate metabolism in chronic liver diseaseScandinavian Journal of Clinical and Laboratory Investigation, 2013
- Glycogen Storage Disease Type IXJournal of Pediatric Gastroenterology and Nutrition, 2012
- Liver glycogen storage diseases due to phosphorylase system deficiencies: Diagnosis thanks to non invasive blood enzymatic and molecular studiesMolecular Genetics and Metabolism, 2011
- Hearing loss in Pompe disease revisited: results from a study of 24 childrenJournal of Inherited Metabolic Disease, 2010
- Glycogen storage disease type IX: High variability in clinical phenotypeMolecular Genetics and Metabolism, 2007
- Diagnostic Accuracy of Blood Lactate-to-Pyruvate Molar Ratio in the Differential Diagnosis of Congenital Lactic AcidosisClinical Chemistry, 2007
- Proximal Renal Tubular Acidosis Associated with Glycogen Storage Disease, Type 9Acta Paediatrica, 1988